{"gene":"MRPL13","run_date":"2026-04-28T18:30:28","timeline":{"discoveries":[{"year":2003,"finding":"Human ribosomal protein L13a is released from the 60S ribosomal subunit upon IFN-γ stimulation, becomes phosphorylated, and in its released form binds the GAIT element in the 3′-UTR of ceruloplasmin mRNA to silence its translation. L13a was identified as the GAIT component by genetic screen and its in vitro translational inhibitory activity was demonstrated with recombinant protein.","method":"Genetic screen for 3′-UTR binding proteins, in vitro translation assay with recombinant protein, ribosomal subunit fractionation, phosphorylation analysis","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods (genetic screen, in vitro assay, fractionation) in a highly-cited foundational paper","pmids":["14567916"],"is_preprint":false},{"year":2007,"finding":"Released L13a blocks translation of GAIT element-containing mRNAs by interacting with eIF4G, preventing 43S ribosomal complex recruitment to the mRNA without disrupting eIF4F complex formation. Sensitivity required IRES elements dependent on eIF4G but not eIF4F-independent IRESs.","method":"IRES-driven reporter assays, 43S assembly assays, protein interaction studies with eIF4G","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1–2 — mechanistic dissection with multiple orthogonal assays identifying the precise initiation factor targeted","pmids":["17218275"],"is_preprint":false},{"year":2007,"finding":"L13a-deficient human U937 cells (>98% knockdown) show rescued ceruloplasmin mRNA translation from IFN-γ-mediated silencing, reduced rRNA methylation, and impaired cap-independent IRES-mediated translation, but normal global translation, rRNA processing, polysome formation, translational fidelity, and cell proliferation, establishing L13a as dispensable for canonical ribosome function but essential for rRNA methylation and GAIT-mediated silencing.","method":"Stable shRNA knockdown, metabolic labeling, ribosome profiling, polysome analysis, IRES reporter assays","journal":"RNA (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 2 — clean near-complete KD with multiple defined phenotypic readouts in a single rigorous study","pmids":["17921318"],"is_preprint":false},{"year":2008,"finding":"IFN-γ activates a kinase cascade in which DAPK phosphorylates and activates ZIPK, which in turn phosphorylates L13a at Ser77, causing its release from the 60S ribosomal subunit and subsequent translational silencing of GAIT element-bearing mRNAs. Both DAPK and ZIPK mRNAs contain functional GAIT elements, creating a negative-feedback module.","method":"Kinase cascade assays, site-directed mutagenesis of Ser77, ribosome fractionation, GAIT element reporter assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1–2 — identified phosphorylation site by mutagenesis, mapped kinase cascade with multiple orthogonal assays","pmids":["18995835"],"is_preprint":false},{"year":2013,"finding":"Macrophage-specific knockout of L13a in mice abrogates translational control of several chemokines (CXCL13, CCL22, CCL8, CCR3), leading to severe LPS-induced endotoxemia with widespread macrophage infiltration, tissue injury, and reduced survival. Macrophages from KO mice fail to form L13a-dependent RNA-binding complexes on target mRNAs and show increased polyribosomal association of these mRNAs.","method":"Conditional macrophage-specific L13a knockout mice, LPS endotoxemia model, ELISA for chemokines, polyribosome profiling, RNA-protein binding assays","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — in vivo KO with multiple mechanistic readouts confirming translation control defect","pmids":["23460747"],"is_preprint":false},{"year":2013,"finding":"Arginine 68 of L13a is essential for rRNA binding and incorporation into the 60S ribosomal subunit. Incorporation occurs during maturation of the 90S preribosome in the nucleolus and is required for rRNA methylation within the 90S complex. Mutations abolishing ribosomal incorporation do not affect L13a phosphorylation or its extraribosomal GAIT silencing function.","method":"Site-directed mutagenesis, ribosome fractionation, nucleolar localization assays, rRNA methylation assays, in vitro GAIT translation assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 — mutagenesis with multiple orthogonal functional readouts separating ribosomal and extraribosomal functions","pmids":["23689135"],"is_preprint":false},{"year":2014,"finding":"L13a acts as an antiviral innate immune factor: upon RSV infection, L13a is released from the 60S subunit and forms a VAIT (RSV-activated inhibitor of translation) complex that recognizes a GAIT-like hairpin in the 3′-UTR of RSV matrix (M) protein mRNA, silencing its translation and suppressing viral replication. RSV growth was enhanced in L13a-deficient cells, and M mRNA showed increased polyribosomal association.","method":"L13a KD in multiple cell lines and L13a KO macrophages, RSV growth assays, polyribosome profiling, RNA-protein interaction studies, in silico RNA structure prediction, translational reporter assays","journal":"Journal of virology","confidence":"High","confidence_rationale":"Tier 2 — multiple cell types and KO model with defined molecular mechanism and antiviral phenotype","pmids":["24899178"],"is_preprint":false},{"year":2014,"finding":"Macrophage-specific L13a knockout on an apoE-deficient background results in significantly increased atherosclerosis, thinner smooth muscle cell media, larger macrophage plaque area, higher plasma inflammatory cytokines, and elevated polyribosomal abundance of target mRNAs in macrophages, demonstrating that L13a-dependent translational control protects against atherosclerosis.","method":"Double knockout mice (L13a flox/ApoE-/-), high-fat diet atherosclerosis model, aortic sinus histology, en face aorta analysis, ELISA, polyribosome profiling","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic model with multiple anatomical and molecular readouts","pmids":["24436370"],"is_preprint":false},{"year":2015,"finding":"Myeloid-specific L13a KO mice subjected to dextran sodium sulfate show severe colitis with accelerated weight loss, rectal bleeding, colon shortening, reduced survival, elevated inflammatory cytokines/chemokines, and abrogated translational silencing of pro-inflammatory mRNAs, revealing L13a-dependent translational control as an endogenous defense against ulcerative colitis.","method":"Myeloid-specific L13a KO mice, DSS colitis model, histopathology, ELISA, polyribosome profiling, cytokine quantification","journal":"Cellular & molecular immunology","confidence":"High","confidence_rationale":"Tier 2 — in vivo KO with defined molecular and pathological phenotypes","pmids":["26166763"],"is_preprint":false},{"year":2019,"finding":"Mutually exclusive amino acid residues in the eukaryote-specific C-terminal extension of human L13a (Tyr149–Val203) are responsible for either ribosomal incorporation or GAIT-mediated translational silencing. Specifically, mutation of Arg169, Lys170, and Lys171 to Ala abrogates GAIT silencing but not ribosomal incorporation. The C-terminal helix alone is sufficient to silence translation of GAIT element-containing mRNAs in vitro. Multiple complex nuclear import signals are present within L13a.","method":"Biochemical mutagenesis of C-terminal extension variants, in vitro translation assays, ribosome fractionation, cellular immunofluorescence","journal":"RNA (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro reconstitution with mutagenesis and multiple functional readouts separating ribosomal and extraribosomal activities","pmids":["31308261"],"is_preprint":false},{"year":2011,"finding":"SRY interacts with ribosomal protein L13a (RPL13a) via the HMG box domain of SRY, as identified by yeast two-hybrid. SRY, RPL13a, and RPS7 co-localize in nuclear speckles in COS1 cells.","method":"Yeast two-hybrid, co-localization by immunofluorescence in COS1 cells","journal":"Cell biology international","confidence":"Low","confidence_rationale":"Tier 3 — single yeast two-hybrid plus co-localization, no functional consequence established","pmids":["21114473"],"is_preprint":false},{"year":2019,"finding":"RPL13 de novo missense and splice variants (causing 18-amino acid insertions) in humans cause spondyloepimetaphyseal dysplasia (SEMD). The insertion-containing protein is stably expressed and incorporated into 60S subunits similarly to wild-type, with no major pre-rRNA processing disturbance, but erythroid proliferation and ribosome profiles on sucrose gradients are altered, suggesting altered translation dynamics. RPL13 is expressed at high levels in chondrocytes and osteoblasts.","method":"Patient cell studies, sucrose gradient ribosome profiling, erythroid proliferation assays, immunohistochemistry of mouse growth plates","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2–3 — patient-derived cells with ribosome profiling and erythroid assays, but functional mechanism not fully defined","pmids":["31630789"],"is_preprint":false},{"year":2020,"finding":"RPL13 missense mutations in patient-derived fibroblasts causing SEMD show normal eL13 expression and subcellular localization but reduced co-localization with eL28 (p<0.001), an increased 60S:80S subunit ratio (p=0.007), and attenuated global translation (p=0.017). An rpl13 CRISPR-Cas9 zebrafish model exhibits cartilage deformities, confirming the role of eL13 in skeletogenesis.","method":"Patient-derived fibroblast studies, co-localization assays, sucrose gradient ribosome profiling, translation assays, CRISPR-Cas9 zebrafish model","journal":"Journal of bone and mineral research","confidence":"Medium","confidence_rationale":"Tier 2 — patient cells plus in vivo vertebrate model with multiple mechanistic readouts","pmids":["32916022"],"is_preprint":false},{"year":2021,"finding":"MRPL13 (mitochondrial ribosomal protein L13) knockdown in breast cancer cells significantly suppresses phosphorylation of AKT and mTOR, inhibits proliferation, migration, and EMT-related gene expression; these effects are partially rescued by the PI3K agonist 740Y-P, placing MRPL13 upstream of PI3K/AKT/mTOR signaling in breast cancer cells.","method":"RNAi-mediated knockdown, proliferation and migration assays, Western blotting for p-AKT and p-mTOR, PI3K agonist rescue experiment","journal":"Cancer management and research","confidence":"Medium","confidence_rationale":"Tier 2–3 — KD with pathway rescue, but single lab and limited mechanistic depth","pmids":["33658859"],"is_preprint":false},{"year":2022,"finding":"In BRAF-inhibitor-treated melanoma cells, L13a-dependent GAIT-like translational repression of HuR mRNA (via a GAIT-like motif near its polyadenylation site PAS2) contributes to HuR insufficiency. Knockdown of L13a or inhibition of the DAPK1-ZIPK axis reduces the proportion of HuR-low cells and attenuates adaptive resistance to BRAF inhibition.","method":"Overexpression of wild-type and mutant HuR mRNA constructs, in vivo RNA-protein interaction assays, L13a KD, DAPK1-ZIPK inhibition, BRAF inhibitor treatment","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2–3 — multiple methods identifying a new GAIT-like target mRNA for L13a with functional consequence","pmids":["35970041"],"is_preprint":false},{"year":2014,"finding":"The human mitochondrial large ribosomal subunit structure determined by cryo-EM to 3.4 Å resolution includes MRPL13 as one of 48 proteins, including 21 mitoribosome-specific proteins, establishing MRPL13 as a structural component of the mammalian mitoribosome.","method":"Single-particle cryo-electron microscopy at 3.4 Å resolution","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — high-resolution cryo-EM structure directly visualizing MRPL13 within the mitoribosome","pmids":["25278503"],"is_preprint":false},{"year":2017,"finding":"Cryo-EM structures of two late-stage human mitoribosomal large subunit assembly intermediates (~3 Å) reveal the sequential incorporation of proteins including MRPL13 during the final steps of mt-LSU maturation, providing insight into the timing of rRNA folding and protein incorporation.","method":"Cryo-EM of native assembly intermediates isolated from human cells, ~3 Å resolution","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 — high-resolution cryo-EM with direct structural visualization of assembly intermediates","pmids":["28892042"],"is_preprint":false},{"year":2025,"finding":"MRPL13 specifically interacts with SLC25A6 (ANT3) and promotes its degradation via K48-linked ubiquitination. This interaction inhibits mitochondrial permeability transition pore (mPTP) opening, preventing cytochrome c release, suppressing cell death, and maintaining OXPHOS and ATP levels in ovarian cancer cells. MRPL13 knockdown impairs OXPHOS, increases ROS, causes mitochondrial depolarization and mPTP opening.","method":"Co-immunoprecipitation, ubiquitination assays (K48-linkage), MRPL13 overexpression/knockdown, mitochondrial membrane potential assays, ROS measurement, ATP measurement, cytochrome c release assay, in vivo xenograft","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP with ubiquitination evidence and multiple mitochondrial functional readouts, single lab","pmids":["40841355"],"is_preprint":false},{"year":2025,"finding":"Knockdown of MRPL13 in trophoblast cells (HTR8/SVneo, BeWo) aggravates mitochondrial unfolded protein response (UPRmt), depletes HSP60 and CLPP, promotes mitochondrial dysfunction, inhibits cell migration, and enhances autophagy, with effects exacerbated under ER stress. MRPL13 expression is significantly reduced in early-onset preeclampsia placental tissues.","method":"siRNA knockdown in trophoblast cell lines, proteomics of EOPE vs. control placentas, Western blotting, immunofluorescence, tunicamycin-induced ER stress, migration assays, autophagy quantification","journal":"Reproduction (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2–3 — KD with multiple functional readouts in cell lines plus clinical proteomics, single lab","pmids":["41630109"],"is_preprint":false},{"year":2025,"finding":"Myeloid-specific L13a KO macrophages show enhanced expression of both M1 and M2 markers and deviate from expected polarization responses, with altered phosphorylation of signaling molecules. Single-cell RNA sequencing reveals widespread changes in gene expression and diverse macrophage subpopulations; CD4+ T cells from KO animals show increased Th1 and Th2 signature genes.","method":"Myeloid-specific L13a KO mice, ex vivo BMDM differentiation, bulk and single-cell RNA sequencing, phosphoproteomics of signaling molecules, T cell gene expression analysis","journal":"Journal of leukocyte biology","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo KO with scRNA-seq and multiple polarization readouts, but mechanistic link to L13a's translational activity not fully resolved","pmids":["40631353"],"is_preprint":false},{"year":1994,"finding":"Rat ribosomal protein L13a (202 amino acids, Mr 23,330) was sequenced from cDNA and found to contain a leucine zipper-like motif at its N-terminus and a potential basic region-leucine zipper (bZIP)-like element in its C-terminal region, as well as short repeated sequences. The mouse tum- transplantation antigen P198 is a mutant of the mouse homolog of rat L13a.","method":"cDNA cloning, nucleotide sequencing, deduced amino acid sequence, Southern blot for gene copy number","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — direct sequencing and structural motif identification; foundational sequence characterization","pmids":["8119894"],"is_preprint":false},{"year":1994,"finding":"The yeast nuclear gene MRP-L13 encodes the large subunit mitochondrial ribosomal protein YmL13, preceded by an 86-amino-acid mitochondrial signal peptide (the longest known among yeast mitoribosomal proteins). The gene is single-copy on chromosome XI, its transcription is repressed by glucose, and disruption reduces but does not abolish growth on non-fermentable carbon sources, indicating the protein is not strictly essential for mitochondrial function.","method":"Gene cloning, sequence analysis, N-terminal protein sequencing of purified YmL13, gene disruption by LEU2 insertion, growth assays on fermentable and non-fermentable carbon sources","journal":"Current genetics","confidence":"Medium","confidence_rationale":"Tier 2 — gene disruption with defined growth phenotype and direct protein characterization; foundational yeast ortholog study","pmids":["7954901"],"is_preprint":false},{"year":2024,"finding":"L13a (RPL13a) in fish cells acts as a host antiviral factor against snakehead vesiculovirus (SHVV): overexpression inhibits SHVV replication while knockdown promotes it. SHVV leader RNA directly binds L13a (and RPS8), and this interaction neutralizes L13a's antiviral effect, allowing the virus to promote its own replication.","method":"RNA-protein binding assays, L13a overexpression and knockdown, SHVV replication assays, co-transfection with leader RNA","journal":"Fish & shellfish immunology","confidence":"Low","confidence_rationale":"Tier 3 — performed in fish cells (non-mammalian model), single study; relevant as ortholog function","pmids":["38432538"],"is_preprint":false}],"current_model":"MRPL13/RPL13a is a dual-function ribosomal protein: as a structural component of the 60S (cytoplasmic) and large mitoribosomal subunit, it is incorporated via Arg68-dependent rRNA binding during 90S preribosome maturation and is required for rRNA methylation; upon IFN-γ stimulation or viral infection it is phosphorylated at Ser77 by a DAPK→ZIPK kinase cascade, released from the ribosome, and assembles into the GAIT (or VAIT) complex that binds GAIT-element hairpins in target mRNA 3′-UTRs to block 43S recruitment by interacting with eIF4G, thereby silencing translation of specific inflammatory chemokines and viral matrix proteins to resolve inflammation and restrict viral replication; in the mitochondrion MRPL13 additionally interacts with SLC25A6 to promote its K48-ubiquitin-mediated degradation, suppressing mPTP opening and maintaining oxidative phosphorylation."},"narrative":{"teleology":[{"year":1994,"claim":"Initial cloning of both the yeast mitochondrial MRP-L13 and the rat cytoplasmic L13a established that two distinct genes encode ribosomal L13 proteins in separate compartments, with yeast MRP-L13 disruption reducing but not abolishing non-fermentable growth.","evidence":"Gene cloning, disruption, and protein sequencing in yeast; cDNA cloning and sequence analysis in rat","pmids":["7954901","8119894"],"confidence":"Medium","gaps":["No mammalian mitochondrial MRPL13 functional data yet","Yeast disruption phenotype is partial — redundancy or residual function unexplored"]},{"year":2003,"claim":"The discovery that cytoplasmic L13a is released from 60S subunits upon IFN-γ stimulation and silences ceruloplasmin mRNA translation via the GAIT element established the paradigm of extraribosomal translational control by a ribosomal protein, though this concerns the cytoplasmic paralog RPL13a rather than mitochondrial MRPL13.","evidence":"Genetic screen, in vitro translation assay, ribosomal subunit fractionation, phosphorylation analysis in human monocytic cells","pmids":["14567916"],"confidence":"High","gaps":["Phosphorylation site not yet mapped","Identity of kinase unknown","Relationship to mitochondrial MRPL13 unaddressed"]},{"year":2007,"claim":"The mechanism of GAIT-mediated silencing was resolved: released L13a blocks 43S ribosomal complex recruitment by binding eIF4G, and L13a knockdown showed it is dispensable for global translation but essential for rRNA methylation and GAIT silencing.","evidence":"IRES reporter assays, 43S assembly assays, eIF4G interaction studies; stable shRNA knockdown with metabolic labeling and polysome analysis","pmids":["17218275","17921318"],"confidence":"High","gaps":["Structural basis of L13a–eIF4G interaction unknown","rRNA methylation targets not defined"]},{"year":2008,"claim":"The DAPK→ZIPK kinase cascade was identified as responsible for Ser77 phosphorylation of L13a, triggering its 60S release, with both kinase mRNAs containing GAIT elements creating negative feedback.","evidence":"Kinase cascade assays, Ser77 site-directed mutagenesis, ribosome fractionation, GAIT reporter assays","pmids":["18995835"],"confidence":"High","gaps":["Whether this cascade operates in non-monocytic cells unknown","Structural basis of phosphorylation-dependent release not resolved"]},{"year":2013,"claim":"In vivo macrophage-specific L13a knockout demonstrated that GAIT-mediated translational control of chemokines is physiologically essential for resolving inflammation, as KO mice develop lethal endotoxemia; separately, Arg68 was shown critical for 60S incorporation during 90S preribosome maturation but dispensable for GAIT function.","evidence":"Conditional KO mice with LPS challenge, ELISA, polyribosome profiling; site-directed mutagenesis with ribosome fractionation and nucleolar assays","pmids":["23460747","23689135"],"confidence":"High","gaps":["Whether MRPL13 (mitochondrial) also participates in translational control unknown","GAIT target repertoire not comprehensively defined"]},{"year":2014,"claim":"Cryo-EM at 3.4 Å directly visualized MRPL13 as a structural subunit of the human mitochondrial large ribosomal subunit, and L13a was shown to act as an antiviral factor silencing RSV matrix protein translation via a VAIT complex, while L13a-dependent translational control was found to protect against atherosclerosis in ApoE-null mice.","evidence":"Single-particle cryo-EM of human mt-LSU; RSV growth assays with L13a KD/KO; double-KO atherosclerosis model with histology and polyribosome profiling","pmids":["25278503","24899178","24436370"],"confidence":"High","gaps":["MRPL13's contacts within the mitoribosome not functionally characterized","Whether MRPL13 has extraribosomal roles analogous to RPL13a unknown"]},{"year":2017,"claim":"Cryo-EM of late-stage mt-LSU assembly intermediates revealed the sequential timing of MRPL13 incorporation during mitoribosome biogenesis, establishing its position in the assembly pathway.","evidence":"Cryo-EM of native assembly intermediates at ~3 Å from human cells","pmids":["28892042"],"confidence":"High","gaps":["Assembly factors recruiting MRPL13 not identified","Consequences of MRPL13 depletion on mt-LSU assembly not tested"]},{"year":2019,"claim":"Mutually exclusive residues in the eukaryote-specific C-terminal extension of L13a were mapped for ribosomal incorporation versus GAIT silencing, with Arg169/Lys170/Lys171 specifically required for GAIT function; separately, RPL13 (cytoplasmic) mutations were linked to spondyloepimetaphyseal dysplasia in humans with altered ribosome profiles.","evidence":"Mutagenesis of C-terminal extension with in vitro translation and ribosome fractionation; patient cell ribosome profiling and erythroid assays","pmids":["31308261","31630789"],"confidence":"High","gaps":["Whether MRPL13 C-terminal domain has analogous dual function unknown","SEMD mechanism not fully defined at molecular level"]},{"year":2020,"claim":"RPL13 SEMD mutations were further characterized showing reduced eL13–eL28 co-localization, increased 60S:80S ratio, and attenuated global translation; an rpl13 zebrafish KO confirmed a role in skeletogenesis.","evidence":"Patient fibroblasts with ribosome profiling and co-localization; CRISPR zebrafish model","pmids":["32916022"],"confidence":"Medium","gaps":["Whether MRPL13 contributes to skeletal phenotypes is unexplored","Mechanism by which mutant eL13 alters translation dynamics not resolved"]},{"year":2025,"claim":"Extraribosomal functions of MRPL13 in mitochondria were uncovered: MRPL13 promotes K48-ubiquitination of SLC25A6 to suppress mPTP opening and maintain OXPHOS; separately, MRPL13 depletion activates UPRmt, depletes HSP60/CLPP, impairs trophoblast function, and is reduced in preeclampsia; L13a KO macrophages show dysregulated polarization by scRNA-seq.","evidence":"Co-IP and ubiquitination assays in ovarian cancer cells with mitochondrial functional readouts and xenograft; siRNA in trophoblast lines with proteomics of preeclampsia placentas; myeloid-specific L13a KO with scRNA-seq","pmids":["40841355","41630109","40631353"],"confidence":"Medium","gaps":["Whether MRPL13 directly mediates ubiquitination or recruits an E3 ligase is unknown","UPRmt mechanism linking MRPL13 to HSP60/CLPP not defined","Single-lab findings for SLC25A6 interaction await independent validation"]},{"year":null,"claim":"Key open questions include: whether MRPL13 has translation-independent signaling roles distinct from mitoribosomal function, the identity of the E3 ubiquitin ligase mediating SLC25A6 degradation, and whether MRPL13 mutations cause mitochondrial disease in humans.","evidence":"","pmids":[],"confidence":"Low","gaps":["No MRPL13-specific Mendelian disease identified","No reconstituted structural model of MRPL13–SLC25A6 interaction","Consequences of MRPL13 loss on mitochondrial translation not directly measured"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[15,16]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[17]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[15,16,17,18]},{"term_id":"GO:0005840","term_label":"ribosome","supporting_discovery_ids":[15,16]}],"pathway":[{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[16]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[17]}],"complexes":["mitochondrial large ribosomal subunit (mt-LSU)"],"partners":["SLC25A6"],"other_free_text":[]},"mechanistic_narrative":"MRPL13 is a structural component of the mammalian mitochondrial large ribosomal subunit (mt-LSU), incorporated during late-stage mt-LSU assembly, as directly visualized by high-resolution cryo-EM [PMID:25278503, PMID:28892042]. Beyond its structural role in the mitoribosome, MRPL13 promotes K48-linked ubiquitination and degradation of SLC25A6 (ANT3), thereby inhibiting mitochondrial permeability transition pore opening, maintaining oxidative phosphorylation, and suppressing cytochrome c release [PMID:40841355]. MRPL13 depletion activates the mitochondrial unfolded protein response, depletes HSP60 and CLPP, impairs trophoblast migration, and enhances autophagy, with reduced MRPL13 expression observed in early-onset preeclampsia placentas [PMID:41630109]. Note: the cytoplasmic ribosomal paralog RPL13a (eL13/L13a) possesses a well-characterized extraribosomal function as the translational silencing component of the IFN-γ-activated GAIT complex, where DAPK–ZIPK-dependent Ser77 phosphorylation releases it from 60S subunits to repress GAIT-element-bearing inflammatory mRNAs via eIF4G interaction [PMID:14567916, PMID:18995835, PMID:17218275]."},"prefetch_data":{"uniprot":{"accession":"Q9BYD1","full_name":"Large ribosomal subunit protein uL13m","aliases":["39S ribosomal protein L13, mitochondrial","L13mt","MRP-L13"],"length_aa":178,"mass_kda":20.7,"function":"","subcellular_location":"Mitochondrion","url":"https://www.uniprot.org/uniprotkb/Q9BYD1/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MRPL13","classification":"Not Classified","n_dependent_lines":393,"n_total_lines":1208,"dependency_fraction":0.3253311258278146},"opencell":{"profiled":true,"resolved_as":"RPL13","ensg_id":"ENSG00000167526","cell_line_id":"CID001737","localizations":[{"compartment":"cytoplasmic","grade":3},{"compartment":"nucleolus_gc","grade":2}],"interactors":[{"gene":"DDX21","stoichiometry":10.0},{"gene":"DRG1","stoichiometry":10.0},{"gene":"EIF2S3","stoichiometry":10.0},{"gene":"EIF3B","stoichiometry":10.0},{"gene":"ENY2","stoichiometry":10.0},{"gene":"METAP2","stoichiometry":10.0},{"gene":"RACK1","stoichiometry":10.0},{"gene":"RBM8A","stoichiometry":10.0},{"gene":"RPL11","stoichiometry":10.0},{"gene":"RPS25","stoichiometry":10.0}],"url":"https://opencell.sf.czbiohub.org/target/CID001737","total_profiled":1310},"omim":[{"mim_id":"610200","title":"MITOCHONDRIAL RIBOSOMAL PROTEIN L13; MRPL13","url":"https://www.omim.org/entry/610200"},{"mim_id":"138295","title":"GLUTAMYL-PROLYL-tRNA SYNTHETASE 1; EPRS1","url":"https://www.omim.org/entry/138295"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/MRPL13"},"hgnc":{"alias_symbol":["L13","RPL13","L13mt","RPML13","L13A","uL13m"],"prev_symbol":[]},"alphafold":{"accession":"Q9BYD1","domains":[{"cath_id":"3.90.1180.10","chopping":"13-68_98-166","consensus_level":"high","plddt":95.382,"start":13,"end":166}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BYD1","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BYD1-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BYD1-F1-predicted_aligned_error_v6.png","plddt_mean":93.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MRPL13","jax_strain_url":"https://www.jax.org/strain/search?query=MRPL13"},"sequence":{"accession":"Q9BYD1","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9BYD1.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9BYD1/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BYD1"}},"corpus_meta":[{"pmid":"14567916","id":"PMC_14567916","title":"Regulated release of L13a from the 60S ribosomal subunit as a mechanism of transcript-specific translational control.","date":"2003","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/14567916","citation_count":275,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"621213","id":"PMC_621213","title":"Isolation of eukaryotic ribosomal proteins. Purification and characterization of the 60 S ribosomal subunit proteins La, Lb, Lf, P1, P2, L13', L14, L18', L20, and L38.","date":"1978","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/621213","citation_count":112,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17218275","id":"PMC_17218275","title":"L13a blocks 48S assembly: role of a general initiation factor in mRNA-specific translational control.","date":"2007","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/17218275","citation_count":80,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1002715","id":"PMC_1002715","title":"Isolation of eukaryotic ribosomal proteins. Purification and characterization of the 60 S ribosomal subunit proteins L4, L5, L7, L9, L11, L12, L13, L21, L22, L23, L26, L27, L30, L33, L35', L37, and L39.","date":"1976","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1002715","citation_count":70,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17921318","id":"PMC_17921318","title":"Human ribosomal protein L13a is dispensable for canonical ribosome function but indispensable for efficient rRNA methylation.","date":"2007","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/17921318","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16786168","id":"PMC_16786168","title":"Activation of the ribosomal protein L13 gene in human gastrointestinal cancer.","date":"2006","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16786168","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24132771","id":"PMC_24132771","title":"The rice nuclear gene WLP1 encoding a chloroplast ribosome L13 protein is needed for chloroplast development in rice grown under low temperature conditions.","date":"2013","source":"Plant molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24132771","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23460747","id":"PMC_23460747","title":"An extraribosomal function of ribosomal protein L13a in macrophages resolves inflammation.","date":"2013","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/23460747","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29626096","id":"PMC_29626096","title":"The mitochondrial ribosomal protein L13 is critical for the structural and functional integrity of the mitochondrion in Plasmodium falciparum.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29626096","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31619563","id":"PMC_31619563","title":"Ribosomal Protein L13 Promotes IRES-Driven Translation of Foot-and-Mouth Disease Virus in a Helicase DDX3-Dependent Manner.","date":"2020","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/31619563","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22533734","id":"PMC_22533734","title":"Ribosomal protein l13a as a reference gene for human bone marrow-derived mesenchymal stromal cells during expansion, adipo-, chondro-, and osteogenesis.","date":"2012","source":"Tissue engineering. Part C, Methods","url":"https://pubmed.ncbi.nlm.nih.gov/22533734","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15557250","id":"PMC_15557250","title":"P6 protein of Cauliflower mosaic virus, a translation reinitiator, interacts with ribosomal protein L13 from Arabidopsis thaliana.","date":"2004","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/15557250","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17507274","id":"PMC_17507274","title":"Characterization and expression during development and under environmental stress of the genes encoding ribosomal proteins L11 and L13 in Chironomus riparius.","date":"2007","source":"Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17507274","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33658859","id":"PMC_33658859","title":"MRPL13 Promotes Tumor Cell Proliferation, Migration and EMT Process in Breast Cancer Through the PI3K-AKT-mTOR Pathway.","date":"2021","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/33658859","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24899178","id":"PMC_24899178","title":"Extraribosomal l13a is a specific innate immune factor for antiviral defense.","date":"2014","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/24899178","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34093518","id":"PMC_34093518","title":"Ribosomal Protein L13 Participates in Innate Immune Response Induced by Foot-and-Mouth Disease Virus.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34093518","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24436370","id":"PMC_24436370","title":"Ribosomal protein L13a deficiency in macrophages promotes atherosclerosis by limiting translation control-dependent retardation of inflammation.","date":"2014","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24436370","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31630789","id":"PMC_31630789","title":"RPL13 Variants Cause Spondyloepimetaphyseal Dysplasia with Severe Short Stature.","date":"2019","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31630789","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3884974","id":"PMC_3884974","title":"Cloning and nucleotide sequencing of the genes for ribosomal proteins S9 (rpsI) and L13 (rplM) of Escherichia coli.","date":"1985","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/3884974","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31625562","id":"PMC_31625562","title":"Model system identification of novel congenital heart disease gene candidates: focus on RPL13.","date":"2019","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31625562","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8119894","id":"PMC_8119894","title":"A leucine zipper-like motif and a basic region-leucine zipper-like element in rat ribosomal protein L13a. Identification of the tum- transplantation antigen P198.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8119894","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2644249","id":"PMC_2644249","title":"Chloroplast ribosomal protein L13 is encoded in the nucleus and is considerably larger than its bacterial homologue. Construction, immunoisolation, and nucleotide sequence (including transit peptide) its cDNA clone from an angiosperm.","date":"1989","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2644249","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26166763","id":"PMC_26166763","title":"L13a-dependent translational control in macrophages limits the pathogenesis of colitis.","date":"2015","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26166763","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34285575","id":"PMC_34285575","title":"MRPL13 Act as a Novel Therapeutic Target and Could Promote Cell Proliferation in Non-Small Cell Lung Cancer.","date":"2021","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/34285575","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15465910","id":"PMC_15465910","title":"Effects of the U1C L13 mutation and temperature regulation of yeast commitment complex formation.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15465910","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32916022","id":"PMC_32916022","title":"Novel RPL13 Variants and Variable Clinical Expressivity in a Human Ribosomopathy With Spondyloepimetaphyseal Dysplasia.","date":"2020","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/32916022","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6773542","id":"PMC_6773542","title":"Purification of Drosophila ribosomal proteins. Isolation of proteins S8, S13, S14, S16, S19, S20/L24, S22/L26, S24, S25/S27, S26, S29, L4, L10/L11, L12, L13, L16, L18, L19, L27, 1, 7/8, 9, and 11.","date":"1980","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/6773542","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7954901","id":"PMC_7954901","title":"The yeast nuclear gene MRP-L13 codes for a protein of the large subunit of the mitochondrial ribosome.","date":"1994","source":"Current genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7954901","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31176070","id":"PMC_31176070","title":"Draft genome sequence of a multidrug-resistant blaOXA-69-producing Acinetobacter baumannii L13 isolated from Tarim River sample in China.","date":"2019","source":"Journal of global antimicrobial resistance","url":"https://pubmed.ncbi.nlm.nih.gov/31176070","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23689135","id":"PMC_23689135","title":"Insights into the mechanism of ribosomal incorporation of mammalian L13a protein during ribosome biogenesis.","date":"2013","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23689135","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37827692","id":"PMC_37827692","title":"Multi-omics analysis of MRPL-13 as a tumor-promoting marker from pan-cancer to lung adenocarcinoma.","date":"2023","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/37827692","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16326033","id":"PMC_16326033","title":"Insertional inactivation of the L13a ribosomal protein gene of Drosophila melanogaster identifies a new Minute locus.","date":"2005","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/16326033","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8198561","id":"PMC_8198561","title":"The primary structure of rat ribosomal protein L13.","date":"1994","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8198561","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28078051","id":"PMC_28078051","title":"Complete genome sequence of Pseudomonas brassicacearum strain L13-6-12, a biological control agent from the rhizosphere of potato.","date":"2017","source":"Standards in genomic sciences","url":"https://pubmed.ncbi.nlm.nih.gov/28078051","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14746913","id":"PMC_14746913","title":"Molecular characterization of a light-responsive gene, breast basic conserved protein 1 (OsiBBC1), encoding nuclear-localized protein homologous to ribosomal protein L13 from Oryza sativa indica.","date":"2004","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/14746913","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21114473","id":"PMC_21114473","title":"SRY interacts with ribosomal proteins S7 and L13a in nuclear speckles.","date":"2011","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/21114473","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8364405","id":"PMC_8364405","title":"Involvement of calcium-dependent cysteine protease in fibronectin-induced chemotactic migration of NIH-L13 fibroblasts.","date":"1993","source":"Biochemistry and molecular biology international","url":"https://pubmed.ncbi.nlm.nih.gov/8364405","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2037044","id":"PMC_2037044","title":"Chloroplast ribosomal protein L15, like L1, L13 and L21, is significantly larger than its E. coli homologue.","date":"1991","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/2037044","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10483362","id":"PMC_10483362","title":"UVB and gamma-radiation induce the expression of mRNAs encoding the ribosomal subunit L13A in rat keratinocytes.","date":"1999","source":"Photochemistry and photobiology","url":"https://pubmed.ncbi.nlm.nih.gov/10483362","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37993442","id":"PMC_37993442","title":"Clinical, genetic and structural delineation of RPL13-related spondyloepimetaphyseal dysplasia suggest extra-ribosomal functions of eL13.","date":"2023","source":"NPJ genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37993442","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7035437","id":"PMC_7035437","title":"The gene for ribosomal protein L13, rplM, is located near argR, at about 70 minutes on the Escherichia coli chromosomal linkage map.","date":"1982","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/7035437","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9854818","id":"PMC_9854818","title":"Characterization of a Schistosoma mansoni homologue of the gene encoding the breast basic conserved protein 1/L13 ribosomal protein.","date":"1998","source":"Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9854818","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37121912","id":"PMC_37121912","title":"Evolution of clinical and radiological presentations of spondyloepimetaphyseal dysplasia, RPL13-related: Description of 11 further cases.","date":"2023","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37121912","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35970041","id":"PMC_35970041","title":"Inhibition of the DAPKs-L13a axis prevents a GAIT-like motif-mediated HuR insufficiency in melanoma cells.","date":"2022","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/35970041","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11931584","id":"PMC_11931584","title":"The production of anti-hexapeptide antibodies which recognize the S7, L6 and L13 ribosomal proteins of Escherichia coli.","date":"2002","source":"Journal of peptide science : an official publication of the European Peptide Society","url":"https://pubmed.ncbi.nlm.nih.gov/11931584","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34907725","id":"PMC_34907725","title":"Moonlight human ribosomal protein L13a downregulation is associated with p53 and HER2/neu expression in breast cancer.","date":"2020","source":"Journal of applied biomedicine","url":"https://pubmed.ncbi.nlm.nih.gov/34907725","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38801334","id":"PMC_38801334","title":"Bombyx mori RPL13 participates in UV-induced DNA damage repair of B. mori nucleopolyhedrovirus through interaction with Bm65.","date":"2024","source":"Insect molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/38801334","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31308261","id":"PMC_31308261","title":"Mutually exclusive amino acid residues of L13a are responsible for its ribosomal incorporation and translational silencing leading to resolution of inflammation.","date":"2019","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/31308261","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38187248","id":"PMC_38187248","title":"In silico analyses of pan-squamous cell carcinoma unveiled the immunological implications of MRPL13, which had previously been under-recognized.","date":"2023","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/38187248","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40725227","id":"PMC_40725227","title":"Beyond the Known: Expanding the Clinical and Genetic Spectrum of Rare RPL13-Related Spondyloepimetaphyseal Dysplasia.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40725227","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38432538","id":"PMC_38432538","title":"Snakehead vesiculovirus (SHVV) leader RNA interacts with host antiviral factors RPS8 and L13a and promotes virus replication.","date":"2024","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/38432538","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40841355","id":"PMC_40841355","title":"MRPL13 enhances mitochondrial function and promotes tumor progression in ovarian cancer by inhibiting mPTP opening via SLC25A6.","date":"2025","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/40841355","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40631353","id":"PMC_40631353","title":"Myeloid-specific deficiency of ribosomal protein L13a alters macrophage polarity and diversity during differentiation from bone marrow.","date":"2025","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/40631353","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40220062","id":"PMC_40220062","title":"Adaptive responses of Rhodococcus aetherivorans L13 to oligotrophy: genome and transcriptomic analysis.","date":"2025","source":"Current genetics","url":"https://pubmed.ncbi.nlm.nih.gov/40220062","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41630109","id":"PMC_41630109","title":"MRPL13 deficiency triggers trophoblast mitochondrial unfolded protein response in early-onset preeclampsia.","date":"2026","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/41630109","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38684306","id":"PMC_38684306","title":"[Clinical and genetic analysis of a patient with short stature due to variant of RPL13 gene].","date":"2024","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/38684306","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22658674","id":"PMC_22658674","title":"Insights into RNA biology from an atlas of mammalian mRNA-binding proteins.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22658674","citation_count":1718,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22681889","id":"PMC_22681889","title":"The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.","date":"2012","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/22681889","citation_count":973,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15146197","id":"PMC_15146197","title":"Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.","date":"2004","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/15146197","citation_count":266,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25278503","id":"PMC_25278503","title":"Structure of the large ribosomal subunit from human mitochondria.","date":"2014","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/25278503","citation_count":262,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34800366","id":"PMC_34800366","title":"Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.","date":"2021","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/34800366","citation_count":239,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21531335","id":"PMC_21531335","title":"MTERF4 regulates translation by targeting the methyltransferase NSUN4 to the mammalian mitochondrial ribosome.","date":"2011","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/21531335","citation_count":230,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30033366","id":"PMC_30033366","title":"Mapping the Genetic Landscape of Human Cells.","date":"2018","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/30033366","citation_count":225,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27499296","id":"PMC_27499296","title":"Mitochondrial Protein Interaction Mapping Identifies Regulators of Respiratory Chain Function.","date":"2016","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/27499296","citation_count":220,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27023846","id":"PMC_27023846","title":"Structure and Function of the Mitochondrial Ribosome.","date":"2016","source":"Annual review of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27023846","citation_count":217,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19738201","id":"PMC_19738201","title":"Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6.","date":"2009","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/19738201","citation_count":207,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29568061","id":"PMC_29568061","title":"An AP-MS- and BioID-compatible MAC-tag enables comprehensive mapping of protein interactions and subcellular localizations.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29568061","citation_count":201,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20186120","id":"PMC_20186120","title":"A functional peptidyl-tRNA hydrolase, ICT1, has been recruited into the human mitochondrial ribosome.","date":"2010","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/20186120","citation_count":153,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25900982","id":"PMC_25900982","title":"BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates.","date":"2015","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/25900982","citation_count":149,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32877691","id":"PMC_32877691","title":"A High-Density Human Mitochondrial Proximity Interaction Network.","date":"2020","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/32877691","citation_count":148,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31871319","id":"PMC_31871319","title":"Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanisms.","date":"2019","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/31871319","citation_count":137,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28892042","id":"PMC_28892042","title":"Structures of the human mitochondrial ribosome in native states of assembly.","date":"2017","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28892042","citation_count":136,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27591049","id":"PMC_27591049","title":"SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling.","date":"2016","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/27591049","citation_count":134,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32989298","id":"PMC_32989298","title":"PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase.","date":"2020","source":"Nature chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/32989298","citation_count":129,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33989516","id":"PMC_33989516","title":"The SARS-CoV-2 RNA interactome.","date":"2021","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/33989516","citation_count":129,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18995835","id":"PMC_18995835","title":"DAPK-ZIPK-L13a axis constitutes a negative-feedback module regulating inflammatory gene expression.","date":"2008","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/18995835","citation_count":127,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":26646,"output_tokens":4657,"usd":0.074897},"stage2":{"model":"claude-opus-4-6","input_tokens":8141,"output_tokens":3580,"usd":0.195307},"total_usd":0.553323,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":37911,"output_tokens":5888,"usd":0.101027},"round2_rules_fired":"R2,R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":9739,"output_tokens":2908,"usd":0.182092}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"Human ribosomal protein L13a (RPL13A) is released from the 60S ribosomal subunit upon IFN-γ stimulation, undergoes phosphorylation of the entire cellular pool, and then binds the 3'-UTR GAIT element of ceruloplasmin (Cp) mRNA to silence its translation as part of the GAIT complex.\",\n      \"method\": \"Genetic screen for Cp 3'-UTR binding proteins, in vitro translation inhibition assay with recombinant L13a, metabolic labeling, ribosome fractionation, RNA-protein binding assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (genetic screen, in vitro reconstitution, in vivo fractionation), foundational paper, 275 citations\",\n      \"pmids\": [\"14567916\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Released L13a blocks 48S pre-initiation complex assembly by interacting with eIF4G, preventing 43S recruitment to GAIT element-containing mRNAs without disrupting the eIF4F complex; this silencing requires eIF4G-dependent IRESs and is transcript-specific.\",\n      \"method\": \"IRES-reporter translation assays, co-immunoprecipitation of L13a with eIF4G, 48S complex assembly analysis, ribosome fractionation\",\n      \"journal\": \"Molecular Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mechanistic reconstitution with IRES reporters and direct protein-protein interaction evidence, 80 citations\",\n      \"pmids\": [\"17218275\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"L13a is dispensable for global translational activity and ribosomal RNA processing in human monocytic cells, but is required for efficient rRNA methylation and cap-independent IRES-mediated translation (p27, p53, SNAT2 mRNAs); L13a-deficient ribosomes are competent for polypeptide synthesis.\",\n      \"method\": \"Stable shRNA knockdown (>98% depletion) in U937 cells, metabolic labeling, polysome profiling, translational fidelity assays, rRNA methylation assays\",\n      \"journal\": \"RNA\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with multiple orthogonal readouts, 67 citations\",\n      \"pmids\": [\"17921318\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Macrophage-specific L13a knockout mice exhibit unregulated translation of chemokines (CXCL13, CCL22, CCL8, CCR3) upon LPS-induced endotoxemia, with increased polyribosomal abundance of target mRNAs, demonstrating that L13a-dependent translational silencing is essential for resolving physiological inflammation.\",\n      \"method\": \"Conditional macrophage-specific L13a knockout mice, LPS endotoxemia model, RNA-protein complex formation assay, polyribosome profiling, ELISA for chemokines\",\n      \"journal\": \"Journal of Immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic KO with defined molecular phenotype (polysome profiling, RNA binding), replicated across multiple readouts\",\n      \"pmids\": [\"23460747\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Arginine at position 68 of L13a is essential for rRNA binding and incorporation into the 60S ribosomal subunit; L13a incorporation occurs during 90S preribosome maturation in the nucleolus and is required for rRNA methylation within the 90S complex, but incorporation-deficient mutants retain phosphorylation capacity and GAIT-mediated translational silencing activity.\",\n      \"method\": \"Mutagenesis of L13a (R68A), rRNA-binding assays, ribosome fractionation, nucleolar localization imaging, rRNA methylation assays, GAIT silencing reporter assays\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis combined with multiple biochemical assays dissecting ribosomal vs. extraribosomal functions\",\n      \"pmids\": [\"23689135\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"L13a is released from the 60S ribosomal subunit upon RSV infection and forms a VAIT (RSV-activated inhibitor of translation) complex that specifically binds a GAIT-like hairpin in the 3'-UTR of RSV matrix (M) protein mRNA, silencing its translation and limiting viral replication; this is IFN-γ-independent.\",\n      \"method\": \"L13a knockdown in multiple cell lines, L13a KO macrophages, polyribosome profiling of M mRNA, RNA-protein interaction studies, in silico RNA folding, translational reporter assays\",\n      \"journal\": \"Journal of Virology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including KO cells, polysome profiling, and RNA-protein interaction assays\",\n      \"pmids\": [\"24899178\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Macrophage-specific L13a knockout on an ApoE-deficient background increases atherosclerosis severity, accompanied by higher polyribosomal abundance of inflammatory target mRNAs, demonstrating that L13a-dependent translational control protects against atherosclerosis.\",\n      \"method\": \"Double KO mice (L13a flox/flox Cre+/+ ApoE-/-), high-fat diet model, en face aortic staining, polyribosome profiling, plasma cytokine ELISA\",\n      \"journal\": \"Arteriosclerosis, Thrombosis, and Vascular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic model with direct molecular phenotype (polysome profiling)\",\n      \"pmids\": [\"24436370\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"L13a-dependent translational silencing in macrophages limits the severity of dextran sodium sulfate-induced colitis in mice, as myeloid-specific L13a KO animals show elevated pro-inflammatory cytokines/chemokines with abrogation of their translational silencing.\",\n      \"method\": \"Myeloid-specific L13a KO mice, DSS colitis model, ELISA, polyribosome profiling, histopathology\",\n      \"journal\": \"Cellular & Molecular Immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo KO model with molecular readouts (polysome profiling) in a defined disease model\",\n      \"pmids\": [\"26166763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Mutually exclusive amino acid residues in the eukaryote-specific C-terminal α-helical extension of L13a (Tyr149-Val203) mediate either ribosomal incorporation or GAIT-mediated translational silencing; mutation of Arg169, Lys170, Lys171 to Ala abrogates GAIT silencing but not ribosomal incorporation, and the C-terminal helix alone can silence GAIT element-containing mRNA translation in vitro.\",\n      \"method\": \"Alanine-scanning mutagenesis of C-terminal extension, GAIT reporter translation assays in vitro, ribosomal incorporation assays, cellular immunofluorescence\",\n      \"journal\": \"RNA\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis with in vitro reconstitution and multiple functional readouts dissecting ribosomal vs. extraribosomal roles\",\n      \"pmids\": [\"31308261\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Rat ribosomal protein L13a has 202 amino acids with a leucine zipper-like motif at its N-terminus and a basic region-leucine zipper-like element in the C-terminal region; it is encoded by 9-11 gene copies and is the mouse homolog of tumor transplantation antigen P198 (a mutant form).\",\n      \"method\": \"cDNA sequencing, protein sequence deduction, Southern blot hybridization, Northern blot\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — structural characterization from cDNA sequence; functional domains inferred from sequence homology\",\n      \"pmids\": [\"8119894\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RPL13a physically interacts with the HMG box domain of SRY and co-localizes with SRY and RPS7 in nuclear speckles in COS1 cells.\",\n      \"method\": \"Yeast two-hybrid screen, co-localization imaging in COS1 cells\",\n      \"journal\": \"Cell Biology International\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single yeast two-hybrid plus co-localization; no functional consequence of the interaction defined\",\n      \"pmids\": [\"21114473\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"A GAIT-like motif in the 3'-UTR of HuR mRNA interacts with GAIT complex constituents including L13a; phosphorylation of L13a via the DAPK1-ZIPK axis and L13a binding to this motif regulate HuR post-transcriptional expression, affecting melanoma cell adaptive response to BRAF inhibition.\",\n      \"method\": \"Overexpression of HuR mutant constructs, in vivo RNA-protein interaction assays, L13a knockdown, DAPK1-ZIPK inhibition\",\n      \"journal\": \"Biochemical and Biophysical Research Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — RNA-protein interaction assay with functional consequence (HuRLow cell proportion), but single lab\",\n      \"pmids\": [\"35970041\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MRPL13 knockdown in breast cancer cells suppresses phosphorylation of AKT and mTOR, inhibits cell proliferation and migration, and reduces EMT-related gene expression; these effects are partially rescued by the PI3K agonist 740Y-P, placing MRPL13 upstream of the PI3K-AKT-mTOR pathway.\",\n      \"method\": \"RNAi knockdown in BC cells, cell proliferation and migration assays, Western blot for pAKT and pmTOR, PI3K agonist rescue experiment\",\n      \"journal\": \"Cancer Management and Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — pathway placement via epistasis (agonist rescue) with KD phenotype, but single lab and limited mechanistic depth for MRPL13 specifically\",\n      \"pmids\": [\"33658859\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MRPL13 specifically interacts with SLC25A6 (ANT3, adenine nucleotide translocator) and promotes its degradation via K48-linked ubiquitination; this inhibits mitochondrial permeability transition pore (mPTP) opening, prevents cytochrome c release, and enhances OXPHOS and ATP production in ovarian cancer cells.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay (K48-linkage specific), MRPL13 overexpression and knockdown, mPTP opening assay, OXPHOS/ATP measurement, cytochrome c release assay, in vivo tumor models\",\n      \"journal\": \"Cell Death & Disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct protein interaction with mechanistic ubiquitination assay and multiple functional readouts, but single lab study\",\n      \"pmids\": [\"40841355\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Myeloid-specific L13a KO macrophages show enhanced expression of both M1 and M2 markers, altered phosphorylation of signaling molecules, and widespread changes in gene expression across diverse macrophage subpopulations (identified by bulk and single-cell RNA-seq), demonstrating a role for L13a beyond binary M1/M2 polarization control.\",\n      \"method\": \"Myeloid-specific L13a KO mice, ex vivo BMDM differentiation, bulk RNA-seq, scRNA-seq, phospho-signaling Western blots\",\n      \"journal\": \"Journal of Leukocyte Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo KO with scRNA-seq and signaling analysis, but mechanistic detail of L13a's direct molecular action in polarization not fully elucidated\",\n      \"pmids\": [\"40631353\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MRPL13 knockdown in trophoblast cells (HTR8/SVneo and BeWo) triggers mitochondrial unfolded protein response (UPRmt), depletes HSP60 and CLPP, reduces OXPHOS and ATP, increases ROS, causes mitochondrial depolarization and mPTP opening, and inhibits cell migration while enhancing autophagy.\",\n      \"method\": \"siRNA knockdown in trophoblast cell lines, Western blot for UPRmt markers, mitochondrial membrane potential assay, ROS measurement, cell migration assay, autophagy assay\",\n      \"journal\": \"Reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — functional KD with multiple mitochondrial readouts, but single lab and mechanism of MRPL13's direct molecular action requires further characterization\",\n      \"pmids\": [\"41630109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The yeast nuclear gene MRP-L13 encodes a large-subunit mitochondrial ribosomal protein (YmL13) with an 86-amino acid N-terminal mitochondrial signal peptide; disruption of MRP-L13 impairs growth on non-fermentable carbon sources, indicating a role in mitochondrial function but not strict essentiality.\",\n      \"method\": \"Gene cloning, protein N-terminal sequencing, gene disruption (LEU2 insertion), growth phenotype on non-fermentable carbon sources\",\n      \"journal\": \"Current Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct gene disruption with defined mitochondrial growth phenotype in yeast ortholog; relevant as foundational for MRPL13 biology\",\n      \"pmids\": [\"7954901\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"RPL13 variants (missense and splice) causing SEMD result in 60S:80S ratio imbalance and attenuated global translation in patient-derived fibroblasts; splice variants produce an 18-amino acid insertion-containing protein that is stably incorporated into 60S subunits; erythroid proliferation and ribosome profiles are altered without significant pre-rRNA processing defects.\",\n      \"method\": \"Patient-derived fibroblast studies, sucrose gradient ribosome profiling, erythroid proliferation assays, pre-rRNA processing assays, Western blot\",\n      \"journal\": \"American Journal of Human Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — patient-derived cells with ribosome profiling and translation assays; multiple orthogonal methods\",\n      \"pmids\": [\"31630789\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"RPL13 missense mutations in patient-derived dermal fibroblasts show normal eL13 expression and proper subcellular localization but reduced colocalization with eL28, increased 60S:80S ratio, and attenuated global translation.\",\n      \"method\": \"Patient-derived fibroblast studies, immunofluorescence colocalization (eL13 vs. eL28), ribosome profiling, global translation assay\",\n      \"journal\": \"Journal of Bone and Mineral Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiment with functional translation consequence, patient-derived cells\",\n      \"pmids\": [\"32916022\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RPL13A/MRPL13 encompasses two distinct proteins: cytoplasmic ribosomal protein L13a (RPL13A), which serves as a structural component of the 60S subunit required for rRNA methylation but dispensable for global translation, and upon IFN-γ stimulation or viral infection is phosphorylated (via DAPK1-ZIPK) and released from the ribosome to form the GAIT or VAIT extraribosomal complex that silences specific target mRNAs (ceruloplasmin, chemokines, viral M protein) by binding their 3'-UTR GAIT-element hairpins and blocking eIF4G-dependent 48S assembly; separately, the mitochondrially-targeted MRPL13 is a large-subunit mitoribosomal protein that supports OXPHOS complex subunit translation, maintains mitochondrial integrity, interacts with SLC25A6 to suppress mPTP opening via K48-ubiquitin-mediated degradation, and promotes tumor cell proliferation partly through PI3K-AKT-mTOR signaling.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"Human ribosomal protein L13a is released from the 60S ribosomal subunit upon IFN-γ stimulation, becomes phosphorylated, and in its released form binds the GAIT element in the 3′-UTR of ceruloplasmin mRNA to silence its translation. L13a was identified as the GAIT component by genetic screen and its in vitro translational inhibitory activity was demonstrated with recombinant protein.\",\n      \"method\": \"Genetic screen for 3′-UTR binding proteins, in vitro translation assay with recombinant protein, ribosomal subunit fractionation, phosphorylation analysis\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (genetic screen, in vitro assay, fractionation) in a highly-cited foundational paper\",\n      \"pmids\": [\"14567916\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Released L13a blocks translation of GAIT element-containing mRNAs by interacting with eIF4G, preventing 43S ribosomal complex recruitment to the mRNA without disrupting eIF4F complex formation. Sensitivity required IRES elements dependent on eIF4G but not eIF4F-independent IRESs.\",\n      \"method\": \"IRES-driven reporter assays, 43S assembly assays, protein interaction studies with eIF4G\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mechanistic dissection with multiple orthogonal assays identifying the precise initiation factor targeted\",\n      \"pmids\": [\"17218275\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"L13a-deficient human U937 cells (>98% knockdown) show rescued ceruloplasmin mRNA translation from IFN-γ-mediated silencing, reduced rRNA methylation, and impaired cap-independent IRES-mediated translation, but normal global translation, rRNA processing, polysome formation, translational fidelity, and cell proliferation, establishing L13a as dispensable for canonical ribosome function but essential for rRNA methylation and GAIT-mediated silencing.\",\n      \"method\": \"Stable shRNA knockdown, metabolic labeling, ribosome profiling, polysome analysis, IRES reporter assays\",\n      \"journal\": \"RNA (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean near-complete KD with multiple defined phenotypic readouts in a single rigorous study\",\n      \"pmids\": [\"17921318\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"IFN-γ activates a kinase cascade in which DAPK phosphorylates and activates ZIPK, which in turn phosphorylates L13a at Ser77, causing its release from the 60S ribosomal subunit and subsequent translational silencing of GAIT element-bearing mRNAs. Both DAPK and ZIPK mRNAs contain functional GAIT elements, creating a negative-feedback module.\",\n      \"method\": \"Kinase cascade assays, site-directed mutagenesis of Ser77, ribosome fractionation, GAIT element reporter assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — identified phosphorylation site by mutagenesis, mapped kinase cascade with multiple orthogonal assays\",\n      \"pmids\": [\"18995835\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Macrophage-specific knockout of L13a in mice abrogates translational control of several chemokines (CXCL13, CCL22, CCL8, CCR3), leading to severe LPS-induced endotoxemia with widespread macrophage infiltration, tissue injury, and reduced survival. Macrophages from KO mice fail to form L13a-dependent RNA-binding complexes on target mRNAs and show increased polyribosomal association of these mRNAs.\",\n      \"method\": \"Conditional macrophage-specific L13a knockout mice, LPS endotoxemia model, ELISA for chemokines, polyribosome profiling, RNA-protein binding assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo KO with multiple mechanistic readouts confirming translation control defect\",\n      \"pmids\": [\"23460747\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Arginine 68 of L13a is essential for rRNA binding and incorporation into the 60S ribosomal subunit. Incorporation occurs during maturation of the 90S preribosome in the nucleolus and is required for rRNA methylation within the 90S complex. Mutations abolishing ribosomal incorporation do not affect L13a phosphorylation or its extraribosomal GAIT silencing function.\",\n      \"method\": \"Site-directed mutagenesis, ribosome fractionation, nucleolar localization assays, rRNA methylation assays, in vitro GAIT translation assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis with multiple orthogonal functional readouts separating ribosomal and extraribosomal functions\",\n      \"pmids\": [\"23689135\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"L13a acts as an antiviral innate immune factor: upon RSV infection, L13a is released from the 60S subunit and forms a VAIT (RSV-activated inhibitor of translation) complex that recognizes a GAIT-like hairpin in the 3′-UTR of RSV matrix (M) protein mRNA, silencing its translation and suppressing viral replication. RSV growth was enhanced in L13a-deficient cells, and M mRNA showed increased polyribosomal association.\",\n      \"method\": \"L13a KD in multiple cell lines and L13a KO macrophages, RSV growth assays, polyribosome profiling, RNA-protein interaction studies, in silico RNA structure prediction, translational reporter assays\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple cell types and KO model with defined molecular mechanism and antiviral phenotype\",\n      \"pmids\": [\"24899178\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Macrophage-specific L13a knockout on an apoE-deficient background results in significantly increased atherosclerosis, thinner smooth muscle cell media, larger macrophage plaque area, higher plasma inflammatory cytokines, and elevated polyribosomal abundance of target mRNAs in macrophages, demonstrating that L13a-dependent translational control protects against atherosclerosis.\",\n      \"method\": \"Double knockout mice (L13a flox/ApoE-/-), high-fat diet atherosclerosis model, aortic sinus histology, en face aorta analysis, ELISA, polyribosome profiling\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic model with multiple anatomical and molecular readouts\",\n      \"pmids\": [\"24436370\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Myeloid-specific L13a KO mice subjected to dextran sodium sulfate show severe colitis with accelerated weight loss, rectal bleeding, colon shortening, reduced survival, elevated inflammatory cytokines/chemokines, and abrogated translational silencing of pro-inflammatory mRNAs, revealing L13a-dependent translational control as an endogenous defense against ulcerative colitis.\",\n      \"method\": \"Myeloid-specific L13a KO mice, DSS colitis model, histopathology, ELISA, polyribosome profiling, cytokine quantification\",\n      \"journal\": \"Cellular & molecular immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo KO with defined molecular and pathological phenotypes\",\n      \"pmids\": [\"26166763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Mutually exclusive amino acid residues in the eukaryote-specific C-terminal extension of human L13a (Tyr149–Val203) are responsible for either ribosomal incorporation or GAIT-mediated translational silencing. Specifically, mutation of Arg169, Lys170, and Lys171 to Ala abrogates GAIT silencing but not ribosomal incorporation. The C-terminal helix alone is sufficient to silence translation of GAIT element-containing mRNAs in vitro. Multiple complex nuclear import signals are present within L13a.\",\n      \"method\": \"Biochemical mutagenesis of C-terminal extension variants, in vitro translation assays, ribosome fractionation, cellular immunofluorescence\",\n      \"journal\": \"RNA (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro reconstitution with mutagenesis and multiple functional readouts separating ribosomal and extraribosomal activities\",\n      \"pmids\": [\"31308261\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"SRY interacts with ribosomal protein L13a (RPL13a) via the HMG box domain of SRY, as identified by yeast two-hybrid. SRY, RPL13a, and RPS7 co-localize in nuclear speckles in COS1 cells.\",\n      \"method\": \"Yeast two-hybrid, co-localization by immunofluorescence in COS1 cells\",\n      \"journal\": \"Cell biology international\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single yeast two-hybrid plus co-localization, no functional consequence established\",\n      \"pmids\": [\"21114473\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"RPL13 de novo missense and splice variants (causing 18-amino acid insertions) in humans cause spondyloepimetaphyseal dysplasia (SEMD). The insertion-containing protein is stably expressed and incorporated into 60S subunits similarly to wild-type, with no major pre-rRNA processing disturbance, but erythroid proliferation and ribosome profiles on sucrose gradients are altered, suggesting altered translation dynamics. RPL13 is expressed at high levels in chondrocytes and osteoblasts.\",\n      \"method\": \"Patient cell studies, sucrose gradient ribosome profiling, erythroid proliferation assays, immunohistochemistry of mouse growth plates\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — patient-derived cells with ribosome profiling and erythroid assays, but functional mechanism not fully defined\",\n      \"pmids\": [\"31630789\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"RPL13 missense mutations in patient-derived fibroblasts causing SEMD show normal eL13 expression and subcellular localization but reduced co-localization with eL28 (p<0.001), an increased 60S:80S subunit ratio (p=0.007), and attenuated global translation (p=0.017). An rpl13 CRISPR-Cas9 zebrafish model exhibits cartilage deformities, confirming the role of eL13 in skeletogenesis.\",\n      \"method\": \"Patient-derived fibroblast studies, co-localization assays, sucrose gradient ribosome profiling, translation assays, CRISPR-Cas9 zebrafish model\",\n      \"journal\": \"Journal of bone and mineral research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — patient cells plus in vivo vertebrate model with multiple mechanistic readouts\",\n      \"pmids\": [\"32916022\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MRPL13 (mitochondrial ribosomal protein L13) knockdown in breast cancer cells significantly suppresses phosphorylation of AKT and mTOR, inhibits proliferation, migration, and EMT-related gene expression; these effects are partially rescued by the PI3K agonist 740Y-P, placing MRPL13 upstream of PI3K/AKT/mTOR signaling in breast cancer cells.\",\n      \"method\": \"RNAi-mediated knockdown, proliferation and migration assays, Western blotting for p-AKT and p-mTOR, PI3K agonist rescue experiment\",\n      \"journal\": \"Cancer management and research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — KD with pathway rescue, but single lab and limited mechanistic depth\",\n      \"pmids\": [\"33658859\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In BRAF-inhibitor-treated melanoma cells, L13a-dependent GAIT-like translational repression of HuR mRNA (via a GAIT-like motif near its polyadenylation site PAS2) contributes to HuR insufficiency. Knockdown of L13a or inhibition of the DAPK1-ZIPK axis reduces the proportion of HuR-low cells and attenuates adaptive resistance to BRAF inhibition.\",\n      \"method\": \"Overexpression of wild-type and mutant HuR mRNA constructs, in vivo RNA-protein interaction assays, L13a KD, DAPK1-ZIPK inhibition, BRAF inhibitor treatment\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — multiple methods identifying a new GAIT-like target mRNA for L13a with functional consequence\",\n      \"pmids\": [\"35970041\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The human mitochondrial large ribosomal subunit structure determined by cryo-EM to 3.4 Å resolution includes MRPL13 as one of 48 proteins, including 21 mitoribosome-specific proteins, establishing MRPL13 as a structural component of the mammalian mitoribosome.\",\n      \"method\": \"Single-particle cryo-electron microscopy at 3.4 Å resolution\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution cryo-EM structure directly visualizing MRPL13 within the mitoribosome\",\n      \"pmids\": [\"25278503\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Cryo-EM structures of two late-stage human mitoribosomal large subunit assembly intermediates (~3 Å) reveal the sequential incorporation of proteins including MRPL13 during the final steps of mt-LSU maturation, providing insight into the timing of rRNA folding and protein incorporation.\",\n      \"method\": \"Cryo-EM of native assembly intermediates isolated from human cells, ~3 Å resolution\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution cryo-EM with direct structural visualization of assembly intermediates\",\n      \"pmids\": [\"28892042\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MRPL13 specifically interacts with SLC25A6 (ANT3) and promotes its degradation via K48-linked ubiquitination. This interaction inhibits mitochondrial permeability transition pore (mPTP) opening, preventing cytochrome c release, suppressing cell death, and maintaining OXPHOS and ATP levels in ovarian cancer cells. MRPL13 knockdown impairs OXPHOS, increases ROS, causes mitochondrial depolarization and mPTP opening.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assays (K48-linkage), MRPL13 overexpression/knockdown, mitochondrial membrane potential assays, ROS measurement, ATP measurement, cytochrome c release assay, in vivo xenograft\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP with ubiquitination evidence and multiple mitochondrial functional readouts, single lab\",\n      \"pmids\": [\"40841355\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Knockdown of MRPL13 in trophoblast cells (HTR8/SVneo, BeWo) aggravates mitochondrial unfolded protein response (UPRmt), depletes HSP60 and CLPP, promotes mitochondrial dysfunction, inhibits cell migration, and enhances autophagy, with effects exacerbated under ER stress. MRPL13 expression is significantly reduced in early-onset preeclampsia placental tissues.\",\n      \"method\": \"siRNA knockdown in trophoblast cell lines, proteomics of EOPE vs. control placentas, Western blotting, immunofluorescence, tunicamycin-induced ER stress, migration assays, autophagy quantification\",\n      \"journal\": \"Reproduction (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — KD with multiple functional readouts in cell lines plus clinical proteomics, single lab\",\n      \"pmids\": [\"41630109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Myeloid-specific L13a KO macrophages show enhanced expression of both M1 and M2 markers and deviate from expected polarization responses, with altered phosphorylation of signaling molecules. Single-cell RNA sequencing reveals widespread changes in gene expression and diverse macrophage subpopulations; CD4+ T cells from KO animals show increased Th1 and Th2 signature genes.\",\n      \"method\": \"Myeloid-specific L13a KO mice, ex vivo BMDM differentiation, bulk and single-cell RNA sequencing, phosphoproteomics of signaling molecules, T cell gene expression analysis\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo KO with scRNA-seq and multiple polarization readouts, but mechanistic link to L13a's translational activity not fully resolved\",\n      \"pmids\": [\"40631353\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Rat ribosomal protein L13a (202 amino acids, Mr 23,330) was sequenced from cDNA and found to contain a leucine zipper-like motif at its N-terminus and a potential basic region-leucine zipper (bZIP)-like element in its C-terminal region, as well as short repeated sequences. The mouse tum- transplantation antigen P198 is a mutant of the mouse homolog of rat L13a.\",\n      \"method\": \"cDNA cloning, nucleotide sequencing, deduced amino acid sequence, Southern blot for gene copy number\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct sequencing and structural motif identification; foundational sequence characterization\",\n      \"pmids\": [\"8119894\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The yeast nuclear gene MRP-L13 encodes the large subunit mitochondrial ribosomal protein YmL13, preceded by an 86-amino-acid mitochondrial signal peptide (the longest known among yeast mitoribosomal proteins). The gene is single-copy on chromosome XI, its transcription is repressed by glucose, and disruption reduces but does not abolish growth on non-fermentable carbon sources, indicating the protein is not strictly essential for mitochondrial function.\",\n      \"method\": \"Gene cloning, sequence analysis, N-terminal protein sequencing of purified YmL13, gene disruption by LEU2 insertion, growth assays on fermentable and non-fermentable carbon sources\",\n      \"journal\": \"Current genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gene disruption with defined growth phenotype and direct protein characterization; foundational yeast ortholog study\",\n      \"pmids\": [\"7954901\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"L13a (RPL13a) in fish cells acts as a host antiviral factor against snakehead vesiculovirus (SHVV): overexpression inhibits SHVV replication while knockdown promotes it. SHVV leader RNA directly binds L13a (and RPS8), and this interaction neutralizes L13a's antiviral effect, allowing the virus to promote its own replication.\",\n      \"method\": \"RNA-protein binding assays, L13a overexpression and knockdown, SHVV replication assays, co-transfection with leader RNA\",\n      \"journal\": \"Fish & shellfish immunology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — performed in fish cells (non-mammalian model), single study; relevant as ortholog function\",\n      \"pmids\": [\"38432538\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MRPL13/RPL13a is a dual-function ribosomal protein: as a structural component of the 60S (cytoplasmic) and large mitoribosomal subunit, it is incorporated via Arg68-dependent rRNA binding during 90S preribosome maturation and is required for rRNA methylation; upon IFN-γ stimulation or viral infection it is phosphorylated at Ser77 by a DAPK→ZIPK kinase cascade, released from the ribosome, and assembles into the GAIT (or VAIT) complex that binds GAIT-element hairpins in target mRNA 3′-UTRs to block 43S recruitment by interacting with eIF4G, thereby silencing translation of specific inflammatory chemokines and viral matrix proteins to resolve inflammation and restrict viral replication; in the mitochondrion MRPL13 additionally interacts with SLC25A6 to promote its K48-ubiquitin-mediated degradation, suppressing mPTP opening and maintaining oxidative phosphorylation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"RPL13A (cytoplasmic ribosomal protein L13a) and MRPL13 (mitochondrial ribosomal protein L13) are distinct gene products that function in ribosomal translation and extraribosomal regulation of inflammation and mitochondrial integrity, respectively. RPL13A is a 60S ribosomal subunit component required for rRNA methylation but dispensable for global translation; upon IFN-γ stimulation or viral infection, it is phosphorylated via the DAPK1-ZIPK axis, released from the ribosome, and assembles into the GAIT/VAIT complex, which silences translation of specific mRNAs (ceruloplasmin, chemokines, RSV matrix protein, HuR) by binding 3′-UTR GAIT-element hairpins and blocking eIF4G-dependent 48S ribosome assembly [PMID:14567916, PMID:17218275, PMID:24899178, PMID:35970041]. In vivo, myeloid-specific L13a knockout causes unresolved inflammation in endotoxemia, colitis, and atherosclerosis models due to loss of translational silencing of pro-inflammatory targets, and mutations in RPL13 cause spondyloepimetaphyseal dysplasia (SEMD) through 60S:80S ratio imbalance and attenuated global translation [PMID:23460747, PMID:26166763, PMID:24436370, PMID:31630789]. MRPL13 is a mitoribosomal large-subunit protein that maintains OXPHOS capacity and mitochondrial integrity; it interacts with SLC25A6 to promote its K48-ubiquitin-mediated degradation, thereby suppressing mPTP opening and cytochrome c release, and its depletion triggers the mitochondrial unfolded protein response [PMID:40841355, PMID:41630109].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Establishing MRPL13 as a mitoribosomal protein: the yeast ortholog MRP-L13 was shown to encode a large-subunit mitochondrial ribosomal protein with an N-terminal signal peptide, and its disruption impaired growth on non-fermentable carbon sources, linking it to mitochondrial translation.\",\n      \"evidence\": \"Gene disruption and growth phenotyping in yeast on non-fermentable media\",\n      \"pmids\": [\"7954901\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mammalian MRPL13 function not yet addressed\", \"Substrate specificity of mitoribosome containing YmL13 not defined\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"The rat RPL13A cDNA was cloned, revealing structural features including a leucine zipper-like motif and its identity as the mouse P198 tumor transplantation antigen homolog.\",\n      \"evidence\": \"cDNA sequencing, Southern and Northern blots in rat\",\n      \"pmids\": [\"8119894\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional significance of leucine zipper motifs not tested\", \"No biochemical activity assigned\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"The discovery that RPL13A moonlights as a translational silencer resolved how IFN-γ achieves transcript-specific gene silencing: L13a is phosphorylated and released from the 60S subunit to join the GAIT complex, which binds the ceruloplasmin 3′-UTR GAIT element and represses translation.\",\n      \"evidence\": \"Genetic screen, in vitro translation reconstitution, metabolic labeling, ribosome fractionation in human monocytes\",\n      \"pmids\": [\"14567916\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinase identity for L13a phosphorylation unknown at this point\", \"Mechanism of translational block not yet defined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Two studies defined L13a's dual molecular roles: as a ribosomal component it mediates rRNA methylation but is dispensable for global translation, and as a GAIT effector it blocks 48S pre-initiation complex assembly via direct interaction with eIF4G.\",\n      \"evidence\": \"Stable shRNA knockdown with polysome profiling and rRNA methylation assays; IRES reporters, co-IP of L13a–eIF4G, and 48S assembly analysis\",\n      \"pmids\": [\"17218275\", \"17921318\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of L13a–eIF4G interaction not resolved\", \"How rRNA methylation deficiency affects specific translation programs unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"In vivo genetic evidence established that L13a-dependent translational silencing is physiologically essential for resolving inflammation, and structure-function analysis showed that ribosomal incorporation (requiring Arg68) and GAIT silencing are separable functions.\",\n      \"evidence\": \"Macrophage-specific L13a KO mice with LPS endotoxemia and polysome profiling; R68A mutagenesis with rRNA-binding, ribosome fractionation, and GAIT reporter assays\",\n      \"pmids\": [\"23460747\", \"23689135\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific ribosomal binding site of L13a on 28S rRNA not mapped\", \"In vivo KO phenotype limited to LPS model\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"L13a-mediated translational silencing was extended to antiviral defense and chronic inflammatory disease: L13a forms a VAIT complex that silences RSV matrix protein mRNA independently of IFN-γ, and macrophage-specific L13a KO exacerbates atherosclerosis.\",\n      \"evidence\": \"L13a KO macrophages with RSV infection and polysome profiling; L13a/ApoE double KO mice on high-fat diet with en face aortic staining\",\n      \"pmids\": [\"24899178\", \"24436370\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full repertoire of VAIT target mRNAs not defined\", \"Whether VAIT and GAIT complexes share identical subunit composition unclear\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"The anti-inflammatory role of L13a was further validated in a colitis model, confirming that myeloid-specific L13a KO derepresses pro-inflammatory cytokine translation and worsens mucosal inflammation.\",\n      \"evidence\": \"Myeloid-specific L13a KO mice subjected to DSS colitis, with polysome profiling and ELISA\",\n      \"pmids\": [\"26166763\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether L13a silences targets in non-myeloid cell types in vivo not addressed\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Structural dissection of L13a's C-terminal α-helical extension revealed mutually exclusive residues governing ribosomal incorporation versus GAIT silencing, and RPL13 mutations were linked to spondyloepimetaphyseal dysplasia (SEMD) through 60S:80S imbalance and attenuated global translation.\",\n      \"evidence\": \"Alanine-scanning mutagenesis with in vitro GAIT reporter and ribosomal incorporation assays; patient-derived fibroblasts with sucrose gradient ribosome profiling\",\n      \"pmids\": [\"31308261\", \"31630789\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SEMD pathology involves loss of GAIT function not tested\", \"Atomic structure of L13a C-terminal extension in ribosomal vs. GAIT contexts not available\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"MRPL13 was positioned as a pro-tumorigenic factor upstream of the PI3K-AKT-mTOR pathway, with its knockdown suppressing AKT/mTOR phosphorylation, proliferation, and migration in breast cancer cells.\",\n      \"evidence\": \"RNAi knockdown in breast cancer cells with Western blot for pAKT/pmTOR and PI3K agonist rescue\",\n      \"pmids\": [\"33658859\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct molecular mechanism linking mitoribosomal MRPL13 to PI3K-AKT signaling not identified\", \"Only tested in breast cancer cell lines\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"The GAIT target repertoire was expanded to include HuR mRNA, and the DAPK1-ZIPK kinase axis was identified as the pathway phosphorylating L13a for GAIT complex activation, relevant to melanoma drug resistance.\",\n      \"evidence\": \"In vivo RNA-protein interaction assays, L13a knockdown, DAPK1-ZIPK inhibition in melanoma cells\",\n      \"pmids\": [\"35970041\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether DAPK1-ZIPK directly phosphorylates L13a or acts through intermediaries not fully resolved\", \"Relevance to non-melanoma contexts untested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"MRPL13's mechanism in mitochondrial integrity was elucidated: it interacts with SLC25A6 and promotes its K48-ubiquitin-mediated degradation, suppressing mPTP opening, cytochrome c release, and apoptosis while enhancing OXPHOS in ovarian cancer; separately, MRPL13 depletion in trophoblasts triggers the mitochondrial UPR and mPTP opening.\",\n      \"evidence\": \"Co-IP, K48-ubiquitination assays, mPTP/OXPHOS/ATP measurements, in vivo tumor models; siRNA in trophoblast cell lines with UPRmt marker and mitochondrial functional assays\",\n      \"pmids\": [\"40841355\", \"41630109\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether MRPL13 directly recruits an E3 ubiquitin ligase for SLC25A6 degradation is unknown\", \"Relevance of MRPL13-SLC25A6 axis to normal physiology outside cancer not tested\", \"How loss of a mitoribosomal protein specifically activates UPRmt vs. general translation loss not dissected\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Myeloid-specific L13a KO revealed that L13a governs macrophage polarization beyond classical M1/M2 dichotomy, affecting both M1 and M2 markers and signaling phosphorylation across diverse subpopulations.\",\n      \"evidence\": \"L13a KO BMDMs with bulk RNA-seq, scRNA-seq, and phospho-signaling Western blots\",\n      \"pmids\": [\"40631353\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct translational targets responsible for altered polarization not identified at single-gene resolution\", \"Whether polarization phenotype is cell-autonomous or involves paracrine effects not resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the structural basis for how L13a switches between ribosomal and GAIT conformations, the identity of the E3 ligase mediating MRPL13-dependent SLC25A6 ubiquitination, and the mechanistic link between MRPL13's mitoribosomal function and PI3K-AKT-mTOR signaling.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No cryo-EM or crystal structure of L13a in the GAIT complex\", \"E3 ligase for SLC25A6 not identified\", \"Causal chain from MRPL13 mitoribosomal function to cytoplasmic PI3K-AKT signaling undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [0, 4, 5, 8, 11]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 3, 5, 7]},\n      {\"term_id\": \"GO:0045182\", \"supporting_discovery_ids\": [0, 1, 5, 8]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [2, 4, 16, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005840\", \"supporting_discovery_ids\": [0, 2, 4, 8, 17]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [13, 15, 16]},\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 3, 5, 6, 7, 14]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 1, 2, 4, 8, 17]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [2, 4]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [12, 13]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [13, 15]}\n    ],\n    \"complexes\": [\n      \"GAIT complex\",\n      \"VAIT complex\",\n      \"60S ribosomal subunit\",\n      \"mitoribosomal large subunit\"\n    ],\n    \"partners\": [\n      \"EIF4G1\",\n      \"SLC25A6\",\n      \"DAPK1\",\n      \"ZIPK\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"MRPL13 is a structural component of the mammalian mitochondrial large ribosomal subunit (mt-LSU), incorporated during late-stage mt-LSU assembly, as directly visualized by high-resolution cryo-EM [PMID:25278503, PMID:28892042]. Beyond its structural role in the mitoribosome, MRPL13 promotes K48-linked ubiquitination and degradation of SLC25A6 (ANT3), thereby inhibiting mitochondrial permeability transition pore opening, maintaining oxidative phosphorylation, and suppressing cytochrome c release [PMID:40841355]. MRPL13 depletion activates the mitochondrial unfolded protein response, depletes HSP60 and CLPP, impairs trophoblast migration, and enhances autophagy, with reduced MRPL13 expression observed in early-onset preeclampsia placentas [PMID:41630109]. Note: the cytoplasmic ribosomal paralog RPL13a (eL13/L13a) possesses a well-characterized extraribosomal function as the translational silencing component of the IFN-γ-activated GAIT complex, where DAPK–ZIPK-dependent Ser77 phosphorylation releases it from 60S subunits to repress GAIT-element-bearing inflammatory mRNAs via eIF4G interaction [PMID:14567916, PMID:18995835, PMID:17218275].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Initial cloning of both the yeast mitochondrial MRP-L13 and the rat cytoplasmic L13a established that two distinct genes encode ribosomal L13 proteins in separate compartments, with yeast MRP-L13 disruption reducing but not abolishing non-fermentable growth.\",\n      \"evidence\": \"Gene cloning, disruption, and protein sequencing in yeast; cDNA cloning and sequence analysis in rat\",\n      \"pmids\": [\"7954901\", \"8119894\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No mammalian mitochondrial MRPL13 functional data yet\", \"Yeast disruption phenotype is partial — redundancy or residual function unexplored\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"The discovery that cytoplasmic L13a is released from 60S subunits upon IFN-γ stimulation and silences ceruloplasmin mRNA translation via the GAIT element established the paradigm of extraribosomal translational control by a ribosomal protein, though this concerns the cytoplasmic paralog RPL13a rather than mitochondrial MRPL13.\",\n      \"evidence\": \"Genetic screen, in vitro translation assay, ribosomal subunit fractionation, phosphorylation analysis in human monocytic cells\",\n      \"pmids\": [\"14567916\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphorylation site not yet mapped\", \"Identity of kinase unknown\", \"Relationship to mitochondrial MRPL13 unaddressed\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"The mechanism of GAIT-mediated silencing was resolved: released L13a blocks 43S ribosomal complex recruitment by binding eIF4G, and L13a knockdown showed it is dispensable for global translation but essential for rRNA methylation and GAIT silencing.\",\n      \"evidence\": \"IRES reporter assays, 43S assembly assays, eIF4G interaction studies; stable shRNA knockdown with metabolic labeling and polysome analysis\",\n      \"pmids\": [\"17218275\", \"17921318\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of L13a–eIF4G interaction unknown\", \"rRNA methylation targets not defined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"The DAPK→ZIPK kinase cascade was identified as responsible for Ser77 phosphorylation of L13a, triggering its 60S release, with both kinase mRNAs containing GAIT elements creating negative feedback.\",\n      \"evidence\": \"Kinase cascade assays, Ser77 site-directed mutagenesis, ribosome fractionation, GAIT reporter assays\",\n      \"pmids\": [\"18995835\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this cascade operates in non-monocytic cells unknown\", \"Structural basis of phosphorylation-dependent release not resolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"In vivo macrophage-specific L13a knockout demonstrated that GAIT-mediated translational control of chemokines is physiologically essential for resolving inflammation, as KO mice develop lethal endotoxemia; separately, Arg68 was shown critical for 60S incorporation during 90S preribosome maturation but dispensable for GAIT function.\",\n      \"evidence\": \"Conditional KO mice with LPS challenge, ELISA, polyribosome profiling; site-directed mutagenesis with ribosome fractionation and nucleolar assays\",\n      \"pmids\": [\"23460747\", \"23689135\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether MRPL13 (mitochondrial) also participates in translational control unknown\", \"GAIT target repertoire not comprehensively defined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Cryo-EM at 3.4 Å directly visualized MRPL13 as a structural subunit of the human mitochondrial large ribosomal subunit, and L13a was shown to act as an antiviral factor silencing RSV matrix protein translation via a VAIT complex, while L13a-dependent translational control was found to protect against atherosclerosis in ApoE-null mice.\",\n      \"evidence\": \"Single-particle cryo-EM of human mt-LSU; RSV growth assays with L13a KD/KO; double-KO atherosclerosis model with histology and polyribosome profiling\",\n      \"pmids\": [\"25278503\", \"24899178\", \"24436370\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"MRPL13's contacts within the mitoribosome not functionally characterized\", \"Whether MRPL13 has extraribosomal roles analogous to RPL13a unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Cryo-EM of late-stage mt-LSU assembly intermediates revealed the sequential timing of MRPL13 incorporation during mitoribosome biogenesis, establishing its position in the assembly pathway.\",\n      \"evidence\": \"Cryo-EM of native assembly intermediates at ~3 Å from human cells\",\n      \"pmids\": [\"28892042\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Assembly factors recruiting MRPL13 not identified\", \"Consequences of MRPL13 depletion on mt-LSU assembly not tested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Mutually exclusive residues in the eukaryote-specific C-terminal extension of L13a were mapped for ribosomal incorporation versus GAIT silencing, with Arg169/Lys170/Lys171 specifically required for GAIT function; separately, RPL13 (cytoplasmic) mutations were linked to spondyloepimetaphyseal dysplasia in humans with altered ribosome profiles.\",\n      \"evidence\": \"Mutagenesis of C-terminal extension with in vitro translation and ribosome fractionation; patient cell ribosome profiling and erythroid assays\",\n      \"pmids\": [\"31308261\", \"31630789\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether MRPL13 C-terminal domain has analogous dual function unknown\", \"SEMD mechanism not fully defined at molecular level\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"RPL13 SEMD mutations were further characterized showing reduced eL13–eL28 co-localization, increased 60S:80S ratio, and attenuated global translation; an rpl13 zebrafish KO confirmed a role in skeletogenesis.\",\n      \"evidence\": \"Patient fibroblasts with ribosome profiling and co-localization; CRISPR zebrafish model\",\n      \"pmids\": [\"32916022\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether MRPL13 contributes to skeletal phenotypes is unexplored\", \"Mechanism by which mutant eL13 alters translation dynamics not resolved\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Extraribosomal functions of MRPL13 in mitochondria were uncovered: MRPL13 promotes K48-ubiquitination of SLC25A6 to suppress mPTP opening and maintain OXPHOS; separately, MRPL13 depletion activates UPRmt, depletes HSP60/CLPP, impairs trophoblast function, and is reduced in preeclampsia; L13a KO macrophages show dysregulated polarization by scRNA-seq.\",\n      \"evidence\": \"Co-IP and ubiquitination assays in ovarian cancer cells with mitochondrial functional readouts and xenograft; siRNA in trophoblast lines with proteomics of preeclampsia placentas; myeloid-specific L13a KO with scRNA-seq\",\n      \"pmids\": [\"40841355\", \"41630109\", \"40631353\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether MRPL13 directly mediates ubiquitination or recruits an E3 ligase is unknown\", \"UPRmt mechanism linking MRPL13 to HSP60/CLPP not defined\", \"Single-lab findings for SLC25A6 interaction await independent validation\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include: whether MRPL13 has translation-independent signaling roles distinct from mitoribosomal function, the identity of the E3 ubiquitin ligase mediating SLC25A6 degradation, and whether MRPL13 mutations cause mitochondrial disease in humans.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No MRPL13-specific Mendelian disease identified\", \"No reconstituted structural model of MRPL13–SLC25A6 interaction\", \"Consequences of MRPL13 loss on mitochondrial translation not directly measured\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [15, 16]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [15, 16, 17, 18]},\n      {\"term_id\": \"GO:0005840\", \"supporting_discovery_ids\": [15, 16]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0392499\", \"supporting_discovery_ids\": [15, 16]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [16]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [17]}\n    ],\n    \"complexes\": [\n      \"mitochondrial large ribosomal subunit (mt-LSU)\"\n    ],\n    \"partners\": [\n      \"SLC25A6\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}